Clinical trials: Sotoclax
Newly Diagnosed Multiple Myeloma, T(11;14)
A Single-center, Prospective, Single-arm Clinical Study Exploring the Treatment of Newly Diagnosed Multiple Myeloma Patients With t(11;14) Suitable for Transplantation Using the SonKRd Regimen
The goal of this study is to evaluate treatment of newly diagnosed multiple myeloma patients with t(11;14) suitable for transplantation using the SonKRd regimen, consisting of Sodium Thiotepa, Caffizotide, Lenalidomide, and…
- Conditions
- Newly Diagnosed Multiple Myeloma, T(11;14), Sotoclax, Carfilzomib
- Trial name
- NCT07709884
- Testing
- Sotoclax, Carfilzomib, Lenalidomide
- Where
- China
- Volunteers
- 20 people
- Sponsor
- The First Affiliated Hospital of Soochow University